BECTON, DICKINSON AND COMPANY Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
BECTON, DICKINSON AND COMPANY (BDX) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits of $431.00 million as of 2025-09-30, per its 10-K filed 2025-11-25.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits · last filed 2025-11-25
- 2025-09-30: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $431.00M.
- 2024-09-30: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $405.00M.
- 2023-09-30: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $426.00M.
- 2022-09-30: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $430.00M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits as first filed |
|---|---|---|
| 2025-09-30 | $431.00M 10-K · filed 2025-11-25 | |
| 2024-09-30 | $405.00M 10-K · filed 2025-11-25 | |
| 2023-09-30 | $426.00M 10-K · filed 2024-11-27 | |
| 2022-09-30 | $430.00M 10-K · filed 2023-11-21 | |
| 2021-09-30 | $524.00M 10-K · filed 2022-11-22 | $527.00M 10-K · filed 2021-11-24 |
| 2020-09-30 | $554.00M 10-K · filed 2021-11-24 | |
| 2019-09-30 | $513.00M 10-K · filed 2020-11-25 | |
| 2018-09-30 | $458.00M 10-K · filed 2019-11-27 | |
| 2017-09-30 | $618.00M 10-K · filed 2018-11-21 | |
| 2016-09-30 | $720.00M 10-K · filed 2017-11-22 | |
| 2015-09-30 | $647.00M 10-K · filed 2016-11-23 | |
| 2014-09-30 | $546.00M 10-K · filed 2015-11-25 | $542.00M 10-K · filed 2014-11-26 |
| 2013-09-30 | $478.00M 8-K · filed 2015-03-13 | |
| 2012-09-30 | $606.00M 10-K · filed 2013-11-27 | $606.37M 10-K · filed 2012-11-21 |
| 2011-09-30 | $590.31M 10-K · filed 2012-11-21 | |
| 2010-09-30 | $484.77M 10-K · filed 2011-11-23 | |
| 2009-09-30 | $416.85M 10-K · filed 2010-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |